Compare MTH & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTH | TMDX |
|---|---|---|
| Founded | 1985 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.8B |
| IPO Year | 1997 | 2019 |
| Metric | MTH | TMDX |
|---|---|---|
| Price | $64.25 | $96.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $77.63 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 845.2K | 829.5K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | 0.82 | ★ 4.87 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | N/A | $24.25 |
| Revenue Next Year | $9.81 | $18.75 |
| P/E Ratio | $76.73 | ★ $19.92 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $58.03 | $92.49 |
| 52 Week High | $84.54 | $156.00 |
| Indicator | MTH | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 34.27 |
| Support Level | $58.03 | $93.08 |
| Resistance Level | $71.37 | $131.86 |
| Average True Range (ATR) | 2.34 | 5.45 |
| MACD | -0.46 | -1.15 |
| Stochastic Oscillator | 13.88 | 3.37 |
Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.